{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:11:46Z","timestamp":1787314306475,"version":"build-2736575974"},"reference-count":158,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbc.2026.111219","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:25:18Z","timestamp":1769819118000},"page":"111219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-7372","authenticated-orcid":false,"given":"Aymeric","family":"Ravel-Chapuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9438-2395","authenticated-orcid":false,"given":"Shatha A.","family":"Atieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8071-6944","authenticated-orcid":false,"given":"Chim\u00e8ne","family":"Fahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111219_bib1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbc.2026.111219_bib2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.nmd.2012.05.017","article-title":"Epidemiological surveillance of myotonic dystrophy type 1: a 25-year population-based study","volume":"22","author":"Mathieu","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jbc.2026.111219_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000369343","article-title":"Prevalence of muscular dystrophies: a systematic literature review","volume":"43","author":"Theadom","year":"2014","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jbc.2026.111219_bib4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.1546326","article-title":"An unstable triplet repeat in a gene related to myotonic muscular dystrophy","volume":"255","author":"Fu","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111219_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2019 untranslated region of the gene","volume":"255","author":"Mahadevan","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111219_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ng0692-192","article-title":"Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy","volume":"1","author":"Tsilfidis","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2017.01.007","article-title":"Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes","volume":"44","author":"Yum","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jbc.2026.111219_bib8","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","article-title":"Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy","volume":"19","author":"Miller","year":"2000","journal-title":"Embo J."},{"key":"10.1016\/j.jbc.2026.111219_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib10","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1074\/jbc.M005960200","article-title":"RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1","volume":"276","author":"Timchenko","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111219_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1083\/jcb.201108113","article-title":"The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing","volume":"196","author":"Ravel-Chapuis","year":"2012","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.jbc.2026.111219_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005827","article-title":"Staufen1 regulates multiple alternative splicing events either positively or negatively in DM1 indicating its role as a disease modifier","volume":"12","author":"Bondy-Chorney","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib13","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1093\/nar\/gki698","article-title":"HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence","volume":"33","author":"Kim","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111219_bib14","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/sj.emboj.7601296","article-title":"Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing","volume":"25","author":"Paul","year":"2006","journal-title":"Embo J."},{"key":"10.1016\/j.jbc.2026.111219_bib15","doi-asserted-by":"crossref","first-page":"38427","DOI":"10.1074\/jbc.M111.255224","article-title":"Expanded CUG repeats dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex","volume":"286","author":"Paul","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111219_bib16","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/nar\/gkr1228","article-title":"New function for the RNA helicase p68\/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats","volume":"40","author":"Laurent","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111219_bib17","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.1073\/pnas.1422273112","article-title":"Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68\/DDX5","volume":"112","author":"Jones","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111219_bib18","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1093\/nar\/gku352","article-title":"DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1","volume":"42","author":"Pettersson","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111219_bib19","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1073\/pnas.1907297117","article-title":"HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111219_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","article-title":"Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing","volume":"10","author":"Charlet","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111219_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11067","article-title":"Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy","volume":"7","author":"Freyermuth","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111219_bib22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/hmg\/ddr568","article-title":"Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel","volume":"21","author":"Tang","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2008.11.005","article-title":"Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling","volume":"45","author":"Kimura","year":"2009","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jbc.2026.111219_bib24","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/hmg\/ddi223","article-title":"Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic\/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1","volume":"14","author":"Kimura","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jnr.22551","article-title":"Perspectives on gene therapy in myotonic dystrophy type 1","volume":"89","author":"Magana","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jbc.2026.111219_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mus.22090","article-title":"Therapeutics development in myotonic dystrophy type 1","volume":"44","author":"Foff","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jbc.2026.111219_bib27","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.drudis.2018.08.004","article-title":"RNA-mediated therapies in myotonic dystrophy","volume":"23","author":"Overby","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jbc.2026.111219_bib28","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.3390\/ijms20164017","article-title":"Mitigating RNA toxicity in myotonic dystrophy using small molecules","volume":"20","author":"Reddy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111219_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fneur.2018.00349","article-title":"Small molecules which improve pathogenesis of myotonic dystrophy type 1","volume":"9","author":"L\u00f3pez-Morat\u00f3","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jbc.2026.111219_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103489","article-title":"The myotonic dystrophy type 1 drug development pipeline: 2022 edition","volume":"28","author":"Pascual-Gilabert","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jbc.2026.111219_bib31","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/v4112598","article-title":"dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection","volume":"4","author":"Dabo","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jbc.2026.111219_bib32","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1093\/nar\/27.17.3534","article-title":"Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein","volume":"27","author":"Michalowski","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111219_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S1355838200991544","article-title":"Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR","volume":"6","author":"Tian","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.jbc.2026.111219_bib34","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111219_bib35","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","article-title":"Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons","volume":"13","author":"Jiang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ana.10763","article-title":"Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2","volume":"54","author":"Mankodi","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2026.111219_bib37","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/nar\/gkv029","article-title":"Molecular mechanisms in DM1 - a focus on foci","volume":"43","author":"Pettersson","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111219_bib38","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1096\/fj.09-151159","article-title":"Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells","volume":"24","author":"Huichalaf","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111219_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256276","article-title":"High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1)","volume":"16","author":"Neault","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111219_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0006-291X(03)01318-4","article-title":"Small molecule inhibitors of the RNA-dependent protein kinase","volume":"308","author":"Jammi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111219_bib41","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1016\/j.bmcl.2011.04.149","article-title":"Identification of new inhibitors of protein kinase R guided by statistical modeling","volume":"21","author":"Bryk","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.111219_bib42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1439-7633(20020902)3:9<859::AID-CBIC859>3.0.CO;2-J","article-title":"Selection of small-molecule mediators of the RNA regulation of PKR, the RNA-dependent protein kinase","volume":"3","author":"Carlson","year":"2002","journal-title":"Chembiochem"},{"key":"10.1016\/j.jbc.2026.111219_bib43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11030-016-9689-4","article-title":"Design and synthesis of novel protein kinase R (PKR) inhibitors","volume":"20","author":"Weintraub","year":"2016","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jbc.2026.111219_bib44","article-title":"Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I","volume":"4","author":"Bondy-Chorney","year":"2016","journal-title":"Rare Dis."},{"key":"10.1016\/j.jbc.2026.111219_bib45","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1091\/mbc.e15-06-0356","article-title":"Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients","volume":"27","author":"Ravel-Chapuis","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2026.111219_bib46","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/hmg\/ddx085","article-title":"Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog","volume":"26","author":"Crawford Parks","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib47","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/hmg\/ddaa111","article-title":"Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features","volume":"29","author":"Crawford Parks","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib48","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1101\/gad.220962.113","article-title":"STAU1 binding 3\u2019 UTR IRAlus complements nuclear retention to protect cells from PKR-mediated translational shutdown","volume":"27","author":"Elbarbary","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111219_bib49","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1093\/nar\/gkw312","article-title":"Staufen1 promotes HCV replication by inhibiting protein kinase R and transporting viral RNA to the site of translation and replication in the cells","volume":"44","author":"Dixit","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111219_bib50","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2337\/db07-1769","article-title":"Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes","volume":"57","author":"Schmitz-Peiffer","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2026.111219_bib51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.yjmcc.2011.07.013","article-title":"PKC-delta and PKC-epsilon: foes of the same family or strangers?","volume":"51","author":"Duquesnes","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.jbc.2026.111219_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molcel.2007.07.027","article-title":"Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation","volume":"28","author":"Kuyumcu-Martinez","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111219_bib53","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","article-title":"Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy","volume":"24","author":"Timchenko","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111219_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/5.1.115","article-title":"Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy","volume":"5","author":"Timchenko","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib55","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1074\/jbc.M410781200","article-title":"MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1","volume":"280","author":"Dansithong","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111219_bib56","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1073\/pnas.0708519105","article-title":"Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy","volume":"105","author":"Orengo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111219_bib57","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI32308","article-title":"Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111219_bib58","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng1857","article-title":"Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy","volume":"38","author":"Mahadevan","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib59","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/hmg\/ddi162","article-title":"Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy","volume":"14","author":"Ho","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib60","doi-asserted-by":"crossref","first-page":"35372","DOI":"10.1074\/jbc.M113.507426","article-title":"Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling","volume":"288","author":"Verma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111219_bib61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2012.05.033","article-title":"Regulation of the alternative splicing of sarcoplasmic reticulum Ca(2)(+)-ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway","volume":"423","author":"Zhao","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2026.111219_bib62","article-title":"Disease phenotypes in a mouse model of RNA toxicity are independent of protein kinase C\u03b1 and protein kinase C\u03b2","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111219_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083777","article-title":"Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2","volume":"8","author":"Cardani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111219_bib64","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1172\/JCI37976","article-title":"PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1","volume":"119","author":"Wang","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111219_bib65","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0014-5793(99)01389-7","article-title":"The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity","volume":"460","author":"Hers","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2026.111219_bib66","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/hmg\/ddt542","article-title":"High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines","volume":"23","author":"Ketley","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib67","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.yexcr.2008.04.018","article-title":"Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1","volume":"314","author":"Salisbury","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jbc.2026.111219_bib68","doi-asserted-by":"crossref","first-page":"32806","DOI":"10.1074\/jbc.M605701200","article-title":"Age-specific CUGBP1-eIF2 complex increases translation of CCAAT\/enhancer-binding protein beta in old liver","volume":"281","author":"Timchenko","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111219_bib69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2026.111219_bib70","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1172\/JCI64081","article-title":"GSK3beta mediates muscle pathology in myotonic dystrophy","volume":"122","author":"Jones","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111219_bib71","first-page":"1763","article-title":"mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1","volume":"126","author":"Denis","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jbc.2026.111219_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00155-19","article-title":"Correction of Glycogen synthase kinase 3beta in myotonic dystrophy 1 reduces the mutant RNA and improves postnatal survival of DMSXL mice","volume":"39","author":"Wang","year":"2019","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib73","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jnr.20989","article-title":"Myotonic dystrophy expanded CUG repeats disturb the expression and phosphorylation of tau in PC12 cells","volume":"84","author":"Hern\u00e1ndez-Hern\u00e1ndez","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jbc.2026.111219_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310650","article-title":"Therapeutic targeting of the GSK3\u03b2-CUGBP1 pathway in myotonic dystrophy","volume":"24","author":"Lutz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111219_bib75","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1096\/fj.201700700R","article-title":"Correction of GSK3\u03b2 at young age prevents muscle pathology in mice with myotonic dystrophy type 1","volume":"32","author":"Wei","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111219_bib76","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","article-title":"A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1)","volume":"112","author":"Horrigan","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jbc.2026.111219_bib77","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Sign. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2026.111219_bib78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.12703\/r\/11-32","article-title":"The role of mTORC1 in the regulation of skeletal muscle mass","volume":"11","author":"Bodine","year":"2022","journal-title":"Fac. Rev."},{"key":"10.1016\/j.jbc.2026.111219_bib79","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111219_bib80","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the Rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111219_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib82","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/cdd.2010.33","article-title":"Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells","volume":"17","author":"Loro","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2026.111219_bib83","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41419-020-02756-8","article-title":"MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway","volume":"11","author":"Song","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2026.111219_bib84","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1172\/JCI89616","article-title":"Targeting deregulated AMPK\/mTORC1 pathways improves muscle function in myotonic dystrophy type I","volume":"127","author":"Brockhoff","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111219_bib85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.012485299","article-title":"Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway","volume":"99","author":"Talloczy","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111219_bib86","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.biocel.2004.05.009","article-title":"LC3 conjugation system in mammalian autophagy","volume":"36","author":"Tanida","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib87","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.biocel.2010.08.010","article-title":"Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts","volume":"42","author":"Beffy","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib88","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/dmm.018127","article-title":"Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model","volume":"8","author":"Bargiela","year":"2015","journal-title":"Dis. models Mech."},{"key":"10.1016\/j.jbc.2026.111219_bib89","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ana.26069","article-title":"Staufen1 in human neurodegeneration","volume":"89","author":"Paul","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2026.111219_bib90","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202311127","article-title":"Excessive STAU1 condensate drives mTOR translation and autophagy dysfunction in neurodegeneration","volume":"223","author":"Zhao","year":"2024","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib91","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000065898.61358.09","article-title":"Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM\/DM2","volume":"60","author":"Vihola","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2026.111219_bib92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-010-0637-6","article-title":"Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2","volume":"119","author":"Vihola","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2026.111219_bib93","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/hmg\/10.23.2717","article-title":"Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities","volume":"10","author":"Seznec","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib94","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/ddy192","article-title":"Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1","volume":"27","author":"Morriss","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib95","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10","author":"Mankodi","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111219_bib96","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2010.03.006","article-title":"Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway","volume":"20","author":"Vignaud","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jbc.2026.111219_bib97","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1093\/hmg\/ddq277","article-title":"CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1","volume":"19","author":"Ward","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib98","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/hmg\/ddaa095","article-title":"Increased nuclear but not cytoplasmic activities of CELF1 protein leads to muscle wasting","volume":"29","author":"Cox","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib99","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tem.2015.02.009","article-title":"Expanding roles for AMPK in skeletal muscle plasticity","volume":"26","author":"Mounier","year":"2015","journal-title":"Trends Endocrinology Metabolism: TEM"},{"key":"10.1016\/j.jbc.2026.111219_bib100","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1093\/hmg\/ddy245","article-title":"Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles","volume":"27","author":"Ravel-Chapuis","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib101","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1113\/JP282725","article-title":"Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients","volume":"600","author":"Ravel-Chapuis","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.jbc.2026.111219_bib102","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4103\/1673-5374.276336","article-title":"Resveratrol corrects aberrant splicing of RYR1 pre-mRNA and Ca(2+) signal in myotonic dystrophy type 1 myotubes","volume":"15","author":"Santoro","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jbc.2026.111219_bib103","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.braindev.2014.11.001","article-title":"Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts","volume":"37","author":"Takarada","year":"2015","journal-title":"Brain Dev."},{"key":"10.1016\/j.jbc.2026.111219_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.35","article-title":"In vitro and in vivo modulation of alternative splicing by the biguanide metformin","volume":"4","author":"Laustriat","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jbc.2026.111219_bib105","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/brain\/awy231","article-title":"Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial","volume":"141","author":"Bassez","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2026.111219_bib106","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401145RR","article-title":"The AMPK allosteric activator MK-8722 improves the histology and spliceopathy in myotonic dystrophy type 1 (DM1) skeletal muscle","volume":"38","author":"Ravel-Chapuis","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111219_bib107","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.omtn.2020.11.014","article-title":"Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy","volume":"23","author":"Hu","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jbc.2026.111219_bib108","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1113\/JP277123","article-title":"Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice","volume":"597","author":"Manta","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.jbc.2026.111219_bib109","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/mus.26709","article-title":"Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1","volume":"60","author":"Sharp","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jbc.2026.111219_bib110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/hmg\/ddac222","article-title":"Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner","volume":"32","author":"Misquitta","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib111","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.molmed.2022.04.004","article-title":"Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects","volume":"28","author":"Ravel-Chapuis","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2026.111219_bib112","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156125","article-title":"Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independent of pathophysiological changes","volume":"132","author":"Mikhail","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111219_bib113","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13943","article-title":"A single dose of exercise stimulates skeletal muscle mitochondrial plasticity in myotonic dystrophy type 1","volume":"237","author":"Mikhail","year":"2023","journal-title":"Acta Physiol. (Oxf)"},{"key":"10.1016\/j.jbc.2026.111219_bib114","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163856","article-title":"Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1","volume":"8","author":"Davey","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.111219_bib115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.molcel.2013.03.022","article-title":"Inhibition of AMPK catabolic action by GSK3","volume":"50","author":"Suzuki","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.111219_bib116","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bcp.2007.08.028","article-title":"AICAR positively regulate glycogen synthase activity and LDL receptor expression through Raf-1\/MEK\/p42\/44MAPK\/p90RSK\/GSK-3 signaling cascade","volume":"75","author":"Wang","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111219_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2014.00018","article-title":"TWEAK\/Fn14 signaling axis mediates skeletal muscle atrophy and metabolic dysfunction","volume":"5","author":"Sato","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2026.111219_bib118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/156652412798376107","article-title":"The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting","volume":"12","author":"Bhatnagar","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jbc.2026.111219_bib119","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00109-008-0308-4","article-title":"NF-\u03baB signaling in skeletal muscle: prospects for intervention in muscle diseases","volume":"86","author":"Mourkioti","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jbc.2026.111219_bib120","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2026.111219_bib121","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/hmg\/ddu617","article-title":"TWEAK\/Fn14, a pathway and novel therapeutic target in myotonic dystrophy","volume":"24","author":"Yadava","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150192","article-title":"TWEAK regulates muscle functions in a mouse model of RNA toxicity","volume":"11","author":"Yadava","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111219_bib123","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/MCB.20.4.1278-1290.2000","article-title":"NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase","volume":"20","author":"Zamanian-Daryoush","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib124","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1128\/MCB.20.13.4532-4542.2000","article-title":"PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex","volume":"20","author":"Bonnet","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib125","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.onc.1203448","article-title":"Activation of NF-kappa B by the dsRNA-dependent protein kinase, PKR involves the I kappa B kinase complex","volume":"19","author":"Gil","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.111219_bib126","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/MCB.20.8.2933-2940.2000","article-title":"Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta","volume":"20","author":"Lin","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib127","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/35006090","article-title":"PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes","volume":"404","author":"Sun","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111219_bib128","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41598-018-19822-z","article-title":"GSK3\u03b2 modulates NF-\u03baB activation and RelB degradation through site-specific phosphorylation of BCL10","volume":"8","author":"Abd-Ellah","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111219_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/srep38553","article-title":"GSK-3\u03b2 controls NF-kappaB activity via IKK\u03b3\/NEMO","volume":"6","author":"Medunjanin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111219_bib130","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ki.2014.428","article-title":"Fine-tuning of NF\u03baB by glycogen synthase kinase 3\u03b2 directs the fate of glomerular podocytes upon injury","volume":"87","author":"Bao","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.jbc.2026.111219_bib131","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/ijc.24748","article-title":"Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt","volume":"125","author":"Bai","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.111219_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039945","article-title":"Cross-talk between NFkB and the PI3-kinase\/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis","volume":"7","author":"Hussain","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111219_bib133","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1101\/gad.1662308","article-title":"Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK","volume":"22","author":"Dan","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111219_bib134","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.biocel.2013.06.029","article-title":"Calcineurin: a poorly understood regulator of muscle mass","volume":"45","author":"Hudson","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib135","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1113\/jphysiol.2011.212860","article-title":"The role of in vivo Ca(2)(+) signals acting on Ca(2)(+)-calmodulin-dependent proteins for skeletal muscle plasticity","volume":"589","author":"Tavi","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.jbc.2026.111219_bib136","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1101\/gad.12.16.2499","article-title":"A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type","volume":"12","author":"Chin","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbc.2026.111219_bib137","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1079\/PNS2004362","article-title":"Calcineurin and skeletal muscle growth","volume":"63","author":"Michel","year":"2004","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.jbc.2026.111219_bib138","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/721219","article-title":"The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle","volume":"2010","author":"Sakuma","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jbc.2026.111219_bib139","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/hmg\/ddx109","article-title":"Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice","volume":"26","author":"Ravel-Chapuis","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jcp.20585","article-title":"Protein kinase C theta co-operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells","volume":"207","author":"D'Andrea","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jbc.2026.111219_bib141","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1096\/fj.13-242123","article-title":"Regulatory circuitry of TWEAK-Fn14 system and PGC-1\u03b1 in skeletal muscle atrophy program","volume":"28","author":"Hindi","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111219_bib142","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.275.5308.1930","article-title":"Nuclear export of NF-ATc enhanced by Glycogen synthase Kinase-3","volume":"275","author":"Beals","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111219_bib143","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/ijms23031441","article-title":"Deciphering the complex molecular pathogenesis of myotonic dystrophy type 1 through omics studies","volume":"23","author":"Espinosa-Espinosa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111219_bib144","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.3390\/ijms22168607","article-title":"Transcriptome analysis in a primary human muscle cell differentiation model for myotonic dystrophy type 1","volume":"22","author":"Todorow","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111219_bib145","doi-asserted-by":"crossref","DOI":"10.1242\/bio.058978","article-title":"Myotonic dystrophy type 1 embryonic stem cells show decreased myogenic potential, increased CpG methylation at the DMPK locus and RNA mis-splicing","volume":"11","author":"Franck","year":"2022","journal-title":"Biol. Open"},{"key":"10.1016\/j.jbc.2026.111219_bib146","article-title":"Integrative proteogenomics for differential expression and splicing variation in a DM1 mouse model","volume":"23","author":"Solovyeva","year":"2023","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.jbc.2026.111219_bib147","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/ijerph20032283","article-title":"Automatic text-mining approach to identify molecular target candidates associated with metabolic processes for myotonic dystrophy type 1","volume":"20","author":"Kuntawala","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jbc.2026.111219_bib148","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JND-221645","article-title":"Towards the identification of biomarkers for muscle function improvement in myotonic dystrophy type 1","volume":"10","author":"Aoussim","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jbc.2026.111219_bib149","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3233\/JND-200558","article-title":"Dysregulation of GSK3\u03b2-Target proteins in skin fibroblasts of myotonic dystrophy type 1 (DM1) patients","volume":"8","author":"Grande","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jbc.2026.111219_bib150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12967-023-04369-z","article-title":"Mitochondrial dysfunction: roles in skeletal muscle atrophy","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jbc.2026.111219_bib151","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.biocel.2013.05.039","article-title":"Regulation of muscle protein synthesis and the effects of catabolic States","volume":"45","author":"Gordon","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2003.10.008","article-title":"Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development","volume":"266","author":"Schulz","year":"2004","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jbc.2026.111219_bib153","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jfmk3010012","article-title":"PKC proteins and muscular dystrophy","volume":"3","author":"Gobbi","year":"2018","journal-title":"J. Funct. Morphol. Kinesiol."},{"key":"10.1016\/j.jbc.2026.111219_bib154","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.cellsig.2008.05.005","article-title":"Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1","volume":"20","author":"Kaliman","year":"2008","journal-title":"Cell Signal."},{"key":"10.1016\/j.jbc.2026.111219_bib155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molmed.2011.05.004","article-title":"Myotonic dystrophy mouse models: towards rational therapy development","volume":"17","author":"Gomes-Pereira","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2026.111219_bib156","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng0796-316","article-title":"Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice","volume":"13","author":"Jansen","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib157","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ng0796-325","article-title":"Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy","volume":"13","author":"Reddy","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.111219_bib158","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/genes11091109","article-title":"An overview of alternative splicing defects implicated in myotonic dystrophy type I","volume":"11","author":"L\u00f3pez-Mart\u00ednez","year":"2020","journal-title":"Genes (Basel)"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582600089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582600089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:28:58Z","timestamp":1776382138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582600089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":158,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S002192582600089X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111219","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111219"}}